R. Madhumitha Sri*,
R.M. Aadarshvel,
S. Ravichandran,
- Student, Anna University & Validation Analyst (R&D), Zifo Technology, Chennai, Tamil Nadu, India
- Student, Airlines & Airport Management, Lovely Professional University, Jalandhar, Punjab, India
- Professor, St.Peter’s Institute of Higher Education and Research, Chennai, Tamil Nadu, India
Abstract
Expanding on these foundations, recent structural biology studies using cryo-electron microscopy have provided high-resolution insights into the conformational dynamics of CB₁ and CB₂ receptors. These findings have enabled a more precise understanding of ligand–receptor interactions, particularly how agonists, antagonists, and reverse agonists stabilize distinct receptor states. Such knowledge is critical for rational drug design, allowing researchers to selectively modulate downstream signaling pathways. For instance, CB₁ receptors primarily couple to Gi/o proteins, leading to inhibition of adenylate cyclase, reduced cAMP levels, and modulation of ion channels, whereas CB₂ activation influences immune cell migration and cytokine release. In addition, the therapeutic landscape has shifted toward peripherally restricted CB₁ modulators to avoid central nervous system side effects such as anxiety and depression, which were observed with earlier compounds like rimonabant. Advances in nanotechnology-based drug delivery systems have further improved the bioavailability and targeting precision of cannabinoid-based therapeutics. Moreover, the integration of artificial intelligence in drug discovery pipelines has accelerated the identification of novel cannabinoid ligands with improved safety profiles. Collectively, these developments underscore the growing potential of ECS-targeted therapies in precision medicine, particularly for conditions with limited treatment options.
Keywords: Cannabinoid, CB₁ receptors, cryo-electron microscopy, β-arrestin, G-protein signaling
[This article belongs to International Journal of Cheminformatics ]
R. Madhumitha Sri*, R.M. Aadarshvel, S. Ravichandran. Molecular Dynamics and Therapeutic Architectures of Cannabinoid Receptors: A Comprehensive Review. International Journal of Cheminformatics. 2026; 04(01):36-40.
R. Madhumitha Sri*, R.M. Aadarshvel, S. Ravichandran. Molecular Dynamics and Therapeutic Architectures of Cannabinoid Receptors: A Comprehensive Review. International Journal of Cheminformatics. 2026; 04(01):36-40. Available from: https://journals.stmjournals.com/ijci/article=2026/view=242838
References
- Devane, W. A., et al. (1988). Determination and characterization of a cannabinoid receptor in rat brain. Molecular Pharmacology.
- Munro, S., et al. (1993). Molecular characterization of a peripheral receptor for cannabinoids. Nature.
- Pacher, P., & Kunos, G. (2024). The Endocannabinoid System as a Emerging Target of Pharmacotherapy. Annual Review of Pharmacology and Toxicology.
- Matsuda, L. A., et al. (1990). Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature.
- Alghamdi, A., et al. (2025). Revealing the therapeutic potential of synthetic cannabinoids: a systematic review. Journal of Cannabis Research.
- Goldstein, S. (2026). Minor Cannabinoids: The CBG and CBGA Revolution in Neuroprotection. Phytomedicine Plus.
- Hanuš, L. O., et al. (1999). HU-308: A specific agonist for $CB_2$, a peripheral cannabinoid receptor. PNAS.
- Pertwee, R. G. (2022). Cannabinoid Receptors: Nomenclature and Pharmacological Principles. NIH-PMC.
- Zou, S., & Kumar, U. (2018). Cannabinoid Receptors and the Endocannabinoid System: Signaling and Function in the Central Nervous System. International Journal of Molecular Sciences.
- UNAM Review (2026). The Landscape of Biotransformation in Cannabinoid Tinctures. University of Namibia Science Journal.
| Volume | 04 |
| Issue | 01 |
| Received | 22/04/2026 |
| Accepted | 22/04/2026 |
| Published | 30/04/2026 |
| Publication Time | 8 Days |
Login
PlumX Metrics